4-101257806-T-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000944.5(PPP3CA):​c.59-61690A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0839 in 152,182 control chromosomes in the GnomAD database, including 727 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.084 ( 727 hom., cov: 32)

Consequence

PPP3CA
NM_000944.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.56

Publications

7 publications found
Variant links:
Genes affected
PPP3CA (HGNC:9314): (protein phosphatase 3 catalytic subunit alpha) Enables several functions, including ATPase binding activity; calmodulin binding activity; and calmodulin-dependent protein phosphatase activity. Involved in several processes, including calcineurin-NFAT signaling cascade; peptidyl-serine dephosphorylation; and response to calcium ion. Located in several cellular components, including cytosol; dendritic spine; and nucleoplasm. Part of calcineurin complex. Colocalizes with cytoplasmic side of plasma membrane. Implicated in developmental and epileptic encephalopathy 91. Biomarker of focal segmental glomerulosclerosis and schizophrenia. [provided by Alliance of Genome Resources, Apr 2022]
PPP3CA Gene-Disease associations (from GenCC):
  • arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • developmental and epileptic encephalopathy 91
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.155 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000944.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PPP3CA
NM_000944.5
MANE Select
c.59-61690A>C
intron
N/ANP_000935.1
PPP3CA
NM_001130691.2
c.59-61690A>C
intron
N/ANP_001124163.1
PPP3CA
NM_001130692.2
c.59-61690A>C
intron
N/ANP_001124164.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PPP3CA
ENST00000394854.8
TSL:1 MANE Select
c.59-61690A>C
intron
N/AENSP00000378323.3
PPP3CA
ENST00000394853.8
TSL:1
c.59-61690A>C
intron
N/AENSP00000378322.4
PPP3CA
ENST00000323055.10
TSL:1
c.59-61690A>C
intron
N/AENSP00000320580.6

Frequencies

GnomAD3 genomes
AF:
0.0838
AC:
12737
AN:
152064
Hom.:
717
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0281
Gnomad AMI
AF:
0.0384
Gnomad AMR
AF:
0.0828
Gnomad ASJ
AF:
0.161
Gnomad EAS
AF:
0.164
Gnomad SAS
AF:
0.144
Gnomad FIN
AF:
0.0524
Gnomad MID
AF:
0.127
Gnomad NFE
AF:
0.108
Gnomad OTH
AF:
0.106
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0839
AC:
12764
AN:
152182
Hom.:
727
Cov.:
32
AF XY:
0.0825
AC XY:
6142
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.0283
AC:
1176
AN:
41550
American (AMR)
AF:
0.0828
AC:
1262
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
0.161
AC:
557
AN:
3468
East Asian (EAS)
AF:
0.164
AC:
850
AN:
5178
South Asian (SAS)
AF:
0.146
AC:
705
AN:
4830
European-Finnish (FIN)
AF:
0.0524
AC:
556
AN:
10612
Middle Eastern (MID)
AF:
0.120
AC:
35
AN:
292
European-Non Finnish (NFE)
AF:
0.108
AC:
7352
AN:
67974
Other (OTH)
AF:
0.112
AC:
236
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
588
1177
1765
2354
2942
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
154
308
462
616
770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0973
Hom.:
678
Bravo
AF:
0.0826
Asia WGS
AF:
0.154
AC:
533
AN:
3472

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.35
DANN
Benign
0.59
PhyloP100
-2.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2850965; hg19: chr4-102178963; API